Nicotinic Receptors: From Molecule to Benchside

A special issue of Receptors (ISSN 2813-2564).

Deadline for manuscript submissions: 15 October 2024 | Viewed by 102

Special Issue Editor


E-Mail Website
Guest Editor
Department of Pharmacology, Howard University College of Medicine, Washington, DC 20059, USA
Interests: neurobiological substrates of neuropsychiatric/neurodegenerative disorders including drug addiction, depression, and Parkinson’s disease

Special Issue Information

Dear Colleagues,

Nicotinic receptors, a subclass of ligand-gated ion channels, play a crucial role in diverse physiological processes, ranging from neurotransmission in the central and peripheral nervous systems to immune modulation and beyond. The intricate involvement of nicotinic receptors in health and disease has spurred significant interest in understanding their molecular mechanisms, functional roles, and potential therapeutic applications.

This Special Issue aims to bring together cutting-edge research on nicotinic receptors, providing a platform for scientists and researchers to share their latest findings and insights. Contributions are invited across a spectrum of topics, including, but not limited to, the structural biology of nicotinic receptors, signal transduction pathways, their role in neuronal communication, and emerging therapeutic approaches targeting nicotinic receptors for various medical conditions.

We welcome original research articles, reviews, and perspectives that contribute to the current understanding of nicotinic receptors, addressing both basic science questions and translational aspects. By fostering collaboration and discussion within the scientific community, this Special Issue aspires to deepen our knowledge of nicotinic receptors and pave the way for novel therapeutic interventions in a wide range of neurological/neuropsychiatric and other disorders. This may include central, peripheral, neurodevelopmental, or inflammatory-mediated conditions. Researchers and clinicians are encouraged to share their expertise and contribute to the advancement of this evolving and interdisciplinary field.

Prof. Dr. Yousef Tizabi
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Receptors is an international peer-reviewed open access quarterly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • nicotine
  • nicotinic receptors
  • synaptic transmission
  • neurotransmission
  • signal transduction pathways
  • neuronal communication
  • central nervous system
  • peripheral nervous system
  • neuropharmacology
  • inflammatory diseases
  • neurological diseases
  • neurodevelopmental disorders
  • neuropsychiatric disorders

Published Papers

This special issue is now open for submission.
Back to TopTop